International Session2:Roche Pharma Partnering -Roche capability and expectations to start-ups-

[Roche capability and expectations to start-ups]

Abstract

・Roche has high expectations for innovation in Asia and is strengthening its partnering capabilities in Asia.

・Roche's strategic areas of focus are oncology, immunology, ophthalmology, central nervous system, infectious diseases, rare diseases, and recently personalized healthcare and digital health.

・We are looking for first-in-class and best-in-class partnering opportunities, but if you have a clear point of differentiation from the competition at any stage, please reach out to our partnering department.

Profile

Harm-Jan Borgeld, Head of Roche Pharma Partnering Asia joined Roche as of January 1st, 2021.
Before joining Roche, he spent most of his career at Merck Healthcare KGaA, over 15 years in various positions.
He received his MBA from the Rotterdam School of Management, the Netherlands / Haas 　　
Business School, U.S., and completed his Ph.D. studies at the Medical Faculty of the University of Nagoya, Japan.